Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Observational Study on the Effectiveness and Safety of Vaccination Anti-SARS-CoV2 in Patients With Lung Cancer

NCT05009030 is registered in ClinicalTrials.gov with Fundación GECP as lead sponsor.

NCT NCT05009030
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT05009030 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Observational Study on the Effectiveness and Safety of Vaccination Anti-SARS-CoV2 in Patients With Lung Cancer
Lead sponsor
Fundación GECP
Phase
Observational
Overall status
Completed
Start date
May 6, 2021
Completion date
March 28, 2022
Enrollment
794 (actual)
Sites
51

Conditions

As the registry lists them; a condition with its own page is linked.

covid19, lung cancer